Capro Corp. engages in the manufacture and sale of caprolactam and ammonium sulfate. Its products include Caprolactam, ammonlum sulphate, ammonlum sulphate nitrate, and methylethylketoxime. The company was founded on December 30, 1969 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company